SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-158936
Filing Date
2023-06-01
Accepted
2023-06-01 16:05:55
Documents
13
Period of Report
2023-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d516711d8k.htm   iXBRL 8-K 36002
2 EX-10.1 d516711dex101.htm EX-10.1 3546
  Complete submission text file 0001193125-23-158936.txt   167927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20230601.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20230601_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20230601_pre.xml EX-101.PRE 11717
7 EXTRACTED XBRL INSTANCE DOCUMENT d516711d8k_htm.xml XML 3468
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 23984685
SIC: 2836 Biological Products, (No Diagnostic Substances)